Cargando…
Ixazomib-associated tumor lysis syndrome in multiple myeloma: A case report
RATIONALE: Tumor lysis syndrome (TLS) is an oncologic emergency, but its incidence in MM is rare. To our knowledge, ixazomib has not been associated with TLS in MM. PATIENT CONCERNS: The patient developed TLS after 10 days of treatment with ixazomib, accompanied by renal failure of hyperuricemia, hy...
Autores principales: | Jin, Fengbo, Yang, Mingzhen, Chen, Yingying, Jiang, Lei, Liu, Lixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647543/ https://www.ncbi.nlm.nih.gov/pubmed/33157919 http://dx.doi.org/10.1097/MD.0000000000022632 |
Ejemplares similares
-
An unusual presentation of multiple myeloma with unilateral sudden vision loss: A case report
por: Wu, Pei-Wen, et al.
Publicado: (2017) -
Spotlight on ixazomib: potential in the treatment of multiple myeloma
por: Muz, Barbara, et al.
Publicado: (2016) -
T‐cell pseudolymphoma secondary to ixazomib for multiple myeloma
por: Haq, M., et al.
Publicado: (2021) -
Tumor lysis syndrome in multiple myeloma treated with bortezomib
por: Dhanraj, K. M., et al.
Publicado: (2014) -
Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma
por: Wang, Jiping, et al.
Publicado: (2021)